Faeth Therapeutics, Inc. Patent Applications Pending
33 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-03-28: Application PCTUS2025021991; Invention BISPECIFIC ANTI-VISTA AND ANTI-CD28 BINDING PROTEINS AND USES THEREOF; Applicant SENSEI BIOTHERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2024-12-27: Application 19003692; Invention FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT; Applicant Faeth Therapeutics Inc; Status Docketed New Case - Ready for Examination.
- 2024-08-02: Application PCTUS2024040746; Invention CANCER THERAPIES TARGETING VISTA; Applicant SENSEI BIOTHERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2024-05-29: Application 18676700; Invention PERSONALIZED STARVATION THERAPY FOR CANCER; Applicant Faeth Therapeutics, Inc.; Status Non Final Action Mailed.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | PCTUS2025021991 | BISPECIFIC ANTI-VISTA AND ANTI-CD28 BINDING PROTEINS AND USES THEREOF | SENSEI BIOTHERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | EDWARD H. VAN DER HORST THOMAS A. THISTED | United States United States | ||
| 2024-12-27 | 19003692 | FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT | Faeth Therapeutics Inc | Docketed New Case - Ready for Examination | US20250367169A1 | Oliver D.K. Maddocks | United Kingdom | CENTRAL, DOCKET |
| 2024-08-02 | PCTUS2024040746 | CANCER THERAPIES TARGETING VISTA | SENSEI BIOTHERAPEUTICS, INC. REGENERON PHARMACEUTICALS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | EDWARD H. VAN DER HORST | United States | ||
| 2024-05-29 | 18676700 | PERSONALIZED STARVATION THERAPY FOR CANCER | Faeth Therapeutics, Inc. | Non Final Action Mailed | US20250144067A1 | Oliver D.K. MADDOCKS Swati MISHRA | United Kingdom United Kingdom | JARRELL, NOBLE E |
| 2024-04-09 | 63631577 | BISPECIFIC ANTI-VISTA AND ANTI-CD28 BINDING PROTEINS AND USES THEREOF | Sensei Biotherapeutics, Inc. | Provisional Application Expired | Edward H. VAN DER HORST Thomas A. THISTED | United States United States | ||
| 2024-03-29 | 63571720 | DIETARY REGIMENS AND METHODS FOR TREATMENT OF COLORECTAL CANCER | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. MADDOCKS Virginia CASADAS | United Kingdom United States | ||
| 2023-01-03 | PCTUS2023060025 | PERSONALIZED METHODS OF TREATING CANCER | FAETH THERAPEUTICS, INC. | PCT - International Search Report Mailed to IB | OLIVER D.K. MADDOCKS PETROS A. TYRAKIS HANS JONATHAN GABRIEL LINDSTROM | United States United States United States | KIM, HARRY CHONG HYUN | |
| 2022-12-09 | PCTUS2022081307 | PERSONALIZED STARVATION THERAPY FOR CANCER | FAETH THERAPEUTICS, INC. | PCT - International Search Report Mailed to IB | OLIVER D.K. MADDOCKS SWATI MISHRA | United States United States | KIM, HARRY CHONG HYUN | |
| 2022-11-09 | PCTUS2022079568 | ANTI-VISTA ANTIBODIES AND USES THEREOF | SENSEI BIOTHERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ROBERT PIERCE EDWARD H. VAN DER HORST THOMAS THISTED NADTHAKARN BOLAND NELS NIELSON | United States United States United States United States United States | ||
| 2022-11-09 | 18053996 | ANTI-VISTA ANTIBODIES AND USES THEREOF | Sensei Biotherapeutics, Inc. | Response to Non-Final Office Action Entered and Forwarded to Examiner | US20230272082A1 | Robert PIERCE Edward H. VAN DER HORST Thomas THISTED Nadthakarn BOLAND Nels NIELSON | United States United States United States United States United States | CHASE, CAROL ANN |
| 2022-10-20 | PCTUS2022078418 | COMBINATION THERAPY FOR PIK3CA-ASSOCIATED DISEASES OR DISORDERS | FAETH THERAPEUTICS, INC. | PCT - International Search Report Mailed to IB | OLIVER D.K. MADDOCKS TODD YOUNG MARCUS GONCALVES | United States United States United States | KIM, HARRY CHONG HYUN | |
| 2022-09-19 | PCTUS2022076643 | METHODS OF DETERMINING METABOLIC TARGETS AND DESIGNING NUTRIENT MODULATING TREATMENTS | FAETH THERAPEUTICS, INC. | PCT - International Search Report Mailed to IB | HANS JONATHAN GABRIEL LINDSTROM OLIVER D.K. MADDOCKS SIMON KNOTT | United States United States United States | KIM, HARRY CHONG HYUN | |
| 2022-08-17 | PCTUS2022040588 | PERSONALIZED MODULATION THERAPY FOR CANCER | FAETH THERAPEUTICS, INC. | PCT - International Search Report Mailed to IB | OLIVER D.K. MADDOCKS PETROS TYRAKIS TODD YOUNG | United States United States United States | THOMAS, SHANE M | |
| 2022-01-03 | 63295970 | PERSONALIZED METHODS OF TREATING CANCER | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D. K. MADDOCKS Petros A. Tyrakis Hans Jonathan Gabriel Lindström | United Kingdom United Kingdom Sweden | ||
| 2021-12-10 | 63288062 | PERSONALIZED STARVATION THERAPY FOR CANCER | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. Maddocks Swati Mishra | United Kingdom United Kingdom | ||
| 2021-11-18 | 63280792 | PERSONALIZED STARVATION THERAPY FOR CANCER | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. Maddocks Petros Tyrakis Todd Young | United Kingdom United Kingdom United States | ||
| 2021-10-21 | 63270297 | COMBINATION THERAPY FOR PIK3CA-ASSOCIATED DISEASES OR DISORDERS | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. Maddocks Todd Young Marcus Goncalves | United Kingdom United States United States | ||
| 2021-09-20 | 63246068 | METHODS OF DETERMINING METABOLIC TARGETS AND DESIGNING NUTRIENT MODULATING TREATMENTS | Faeth Therapeutics, Inc. | Provisional Application Expired | Hans Jonathan Gabriel LINDSTRÖM Oliver D.K. Maddocks Simon KNOTT | Sweden United Kingdom Canada | ||
| 2021-08-18 | 63234517 | PERSONALIZED MODULATION THERAPY FOR CANCER | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. Maddocks Petros Tyrakis | United Kingdom United Kingdom | ||
| 2021-08-18 | 63234507 | PERSONALIZED STARVATION THERAPY FOR CANCER | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. Maddocks Petros Tyrakis Todd Young | United Kingdom United Kingdom United States | ||
| 2021-06-03 | PCTUS2021035780 | PERSONALIZED METHODS OF TREATING CANCER | FAETH THERAPEUTICS, INC. | PCT - International Search Report Mailed to IB | OLIVER D. K. MADDOCKS | United States | KIM, HARRY CHONG HYUN | |
| 2021-06-02 | PCTUS2021035476 | FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT | FAETH THERAPEUTICS, INC. | PCT - International Search Report Mailed to IB | OLIVER D. K. MADDOCKS | United States | KIM, HARRY CHONG HYUN | |
| 2020-06-04 | 63034679 | PERSONALIZED METHODS OF TREATING CANCER | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. Maddocks | United Kingdom | ||
| 2020-06-03 | 63034137 | FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT | Faeth Therapeutics, Inc. | Provisional Application Expired | Oliver D.K. Maddocks | United Kingdom | ||
| 2020-05-01 | PCTUS2020031041 | COMBINATION THERAPIES FOR CANCER | SENSEI BIOTHERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ILDIKO CSIKI HOSSEIN A. GHANBARI | United States United States | ||
| 2019-10-18 | PCTUS2019057029 | COMPOSITIONS AND METHODS FOR MANUFACTURING BACTERIOPHAGE CANCER VACCINES AND USES THEREOF | SENSEI BIOTHERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | SOLOMON S. STEWART SAMINDHI M. WU ILDIKO CSIKI HOSSEIN A. GHANBARI STEVEN A. FULLER | United States United States United States United States United States | ||
| 2019-05-10 | PCTUS2019031854 | ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | SENSEI BIOTHERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | MICHAEL S. LEBOWITZ ZHI-GANG JIANG THOMAS THISTED HOSSEIN A. GHANBARI | United States United States United States United States | ||
| 2019-05-01 | 62841500 | COMBINATION THERAPIES FOR CANCER | SENSEI BIOTHERAPEUTICS, INC. | Provisional Application Expired | Hossein A. Ghanbari IIdiko Csiki | United States United States | ||
| 2019-04-01 | 62827485 | COMPOSITIONS AND METHODS FOR MANUFACTURING BACTERIOPHAGE CANCER VACCINES | SENSEI BIOTHERAPEUTICS, INC. | Provisional Application Expired | Solomon S. Stewart Samindhi M. Wu Steven A. Fuller Hossein A. Ghanbari | United States United States United States United States | ||
| 2019-02-27 | 62811223 | ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | SENSEI BIOTHERAPEUTICS, INC. | Provisional Application Expired | Michael S. Lebowitz Hossein A. Ghanbari Thomas Thisted | United States United States United States | ||
| 2019-01-24 | PCTUS2019014987 | METHODS AND COMPOSITIONS FOR PRESERVING NEUROGENESIS | SENSEI BIOTHERAPEUTICS,INC. | PCT - International Search Report Mailed to IB | ZHI-GANG JIANG HOSSEIN GHANBARI | United States United States | THOMAS, SHANE M | |
| 2018-11-08 | 62757445 | COMPOSITIONS AND METHODS FOR MANUFACTURING BACTERIOPHAGE CANCER VACCINES | SENSEI BIOTHERAPEUTICS, INC. | Provisional Application Expired | Solomon S. Stewart Samindhi M. Wu Steven A. Fuller Hossein A. Ghanbari | United States United States United States United States | ||
| 2018-10-19 | 62748127 | COMPOSITIONS AND METHODS FOR MANUFACTURING BACTERIOPHAGE CANCER VACCINES | SENSEI BIOTHERAPEUTICS, INC. | Provisional Application Expired | Solomon S. Stewart Samindhi M. Wu Steven A. Fuller Hossein A. Ghanbari | United States United States United States United States |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |